130A Veritas In Silico
- 1026
- -20-1.91%
Veritas In Silico News
Veritas In Silico: Notification regarding Achievement of Milestone in Joint Drug Discovery Research with Shionogi & Co., Ltd.
Veritas In Silico: Notice of milestone achievement due to progress in joint drug discovery research with Shionogi Pharmaceutical Co., Ltd.
Veritas In Silico: Change Report
Veritas In Silico: [Delayed] Interim Financial Results - FY2024 1H
Veritas In Silico: Half Year Report - Term 9 (2024/01/01 - 2024/12/31)
Veritas In Silico: Confirmation letter
Veritas In Silico: Fiscal year ending December 2024, 2nd quarter (interim) financial results presentation materials for the 9th period.
Veritas In Silico: Short message on accounting settlement for the 2nd quarter (interim period) of fiscal year ending December 2024 [Japanese standard] (non-consolidated).
Veritas In Silico: Unconsolidated financial statements for the six-month period ending June 30, 2024 [based on Japanese accounting standards]
Change Report
Veritas In Silico: Announcements of individual stocks regarding the achievement of milestones for joint drug discovery research with Takeda Pharmaceuticals sp adr.
Veritas In Silico: Confirmation letter
Veritas In Silico: Quarterly Report - 9th Quarter 1st Quarter (2024/01/01 - 2024/03/31)
Change Report
Veritas In Silico: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Veritas In Silico: Corporate Governance Report 2024/03/15
Veritas In Silico: Extraordinary Report
Veritas In Silico: Financial Report - Term 8 (2023/01/01 - 2023/12/31)
Veritas In Silico: Notice Concerning Results of Third-Party Allotment of Shares and Notice Concerning Partial Changes to the “Notice Concerning Decrease in the Amount of Capital (Capital Reduction)”
Veritas In Silico: Financial results briefing materials for the fiscal year ending 2023/12
Analysis
Price Target
No Data
No Data